BioWorld - Tuesday, August 4, 2026 Breaking News: Best of BioWorld Science: Q2See today's BioWorld Science Home Eccogene divulges new GLP-1R agonists To read the full story, subscribe or sign in
Liver Enzyme Changes During GLP-1 Weight Loss Treatment Clinical trials of semaglutide and tirzepatide have documented that liver enzyme elevations (specifically ALT and AST) are rare and typically mild when they occur
DISCLAIMER : The content in this article is provided for informational purposes only and is not intended as medical advice, or as a substitute for the medical advice of a physician
Optimal Balance Pharmacy compounds and dispenses
MASLD-related HCC: a comprehensive review of the trends, pathophysiology, tumor microenvironment, surveillance, and treatment options
What should you do if you have questions about the storage and usage of semaglutide